National Institute on Drug Abuse (NIDA) is offering this grant to support researchers in translating discoveries into medications for Substance Use Disorders (SUDs) caused by various substances. Applicants should have expertise in developing molecules to treat SUDs and moving them towards FDA approval. The goal of this grant is to advance research in developing medications for SUDs related to tobacco, cannabis, cocaine, methamphetamine, heroin, or prescription opioids.
Opportunity ID: 299296
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-18-020 |
| Funding Opportunity Title: | NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3, Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 06, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 07, 2020 |
| Current Closing Date for Applications: | Sep 07, 2020 |
| Archive Date: | Oct 13, 2020 |
| Estimated Total Program Funding: | $2,000,000 |
| Award Ceiling: | $1,000,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) State governments Special district governments Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments For profit organizations other than small businesses Public and State controlled institutions of higher education City or township governments Native American tribal governments (Federally recognized) Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this award is to support outstanding basic and/or clinical researchers with the vision and expertise to translate research discoveries into medications for the treatment of Substance Use Disorders (SUDs) stemming from tobacco, cannabis, cocaine, methamphetamine, heroin, or prescription opiate use. Eligible applicants must demonstrate the ability to develop molecules with the potential to treat SUDs and advance them in the drug development continuum. The ultimate goal of this FOA is to bring molecules closer to FDA approval. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-18-020.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00236872 | Jun 25, 2018 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00260445 | Jun 25, 2018 | Sep 07, 2020 | View |
Package 1
Mandatory forms
299296 RR_SF424_2_0-2.0.pdf
299296 PHS398_CoverPageSupplement_4_0-4.0.pdf
299296 RR_OtherProjectInfo_1_4-1.4.pdf
299296 PerformanceSite_2_0-2.0.pdf
299296 RR_KeyPersonExpanded_2_0-2.0.pdf
299296 RR_Budget_1_4-1.4.pdf
299296 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
299296 RR_SubawardBudget30_1_4-1.4.pdf
299296 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
299296 RR_SF424_2_0-2.0.pdf
299296 PHS398_CoverPageSupplement_5_0-5.0.pdf
299296 RR_OtherProjectInfo_1_4-1.4.pdf
299296 PerformanceSite_2_0-2.0.pdf
299296 RR_KeyPersonExpanded_2_0-2.0.pdf
299296 RR_Budget_1_4-1.4.pdf
299296 PHS398_ResearchPlan_4_0-4.0.pdf
299296 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
299296 RR_SubawardBudget30_1_4-1.4.pdf
299296 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
